ELVN Enliven Therapeutics, Inc.

NASDAQ

$44.75

Enliven Therapeutics, Inc. (ELVN) Earnings News

Earnings press releases, previews and reviews for Enliven Therapeutics, Inc. (ELVN), newest first.

Wednesday August 5, 2026 4:05 PM ET

Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update

Thursday May 7, 2026 4:05 PM ET

Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update